Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles

Abstract Background To determine if extended chemotherapy improves survival outcomes in patients with platinum-sensitive relapsed epithelial ovarian cancer (EOC) who have residual disease after six cycles of second-line chemotherapy. Methods In this study, 135 EOC patients who experienced platinum-s...

Full description

Bibliographic Details
Main Authors: Se Ik Kim, Woo Yeon Hwang, Maria Lee, Hee Seung Kim, Kidong Kim, Hyun Hoon Chung, Jae Hong No, Jae-Weon Kim, Yong Beom Kim, Noh Hyun Park, Yong-Sang Song, Dong Hoon Suh
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Cancer
Subjects:
Ovarian cancer
Chemotherapy
Extended
Survival outcome
Recurrence
Online Access:https://doi.org/10.1186/s12885-020-07658-8

Internet

https://doi.org/10.1186/s12885-020-07658-8

Similar Items